FDA Inspection
Arevipharma GmbHArevipharma GmbH – FDA Inspection, Sep 16, 2019
Record Details
This FDA Inspection record concerns Arevipharma GmbH, with an inspection on September 16, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA McCulloughJ (Issuing Officer)
View Company Profile
ID · d795ea7c-d802-42db-ae9e-0fbc04a1d9ab
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1141793
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Arevipharma GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 20, 2025 | Not classified | Office of Inspections and Investigations | |
| April 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 8, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Arevipharma GmbH
- FDA Inspection 1288700 - 2025-06-20
- FDA Inspection 969875 - 2016-04-29
- FDA Inspection 808573 - 2012-11-16
- FDA Inspection 576014 - 2009-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.